The RESI (Redefining Early Stage Investments) Conference is an ongoing conference series that provides an international venue for early stage life science companies across Biotech, Medtech, Diagnostics, and Healthcare IT and to source investors from around the globe, create relationships, and eventually, secure funding.

This September, RESI is expanding to include the earliest stage companies from the discovery stage through venture stage: companies seeking grants, seed, angel, series A, and series B funding. Life Science Nation invites tech hubs, entrepreneurs, investors, strategic partners, and service providers to the RESI conference on September 6, 2018 at Boston Marriott Copley Place.